# Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

> **NCT02840812** · PHASE1 · UNKNOWN · sponsor: **Zhejiang Medicine Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Kidney Dysfunction

## Interventions

- **DRUG:** Nemonoxacin

## Key facts

- **NCT ID:** NCT02840812
- **Lead sponsor:** Zhejiang Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-05
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2018-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02840812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02840812, "Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02840812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*